AW
TMO icon

ACG Wealth’s Thermo Fisher Scientific TMO Stock Holding History

ACG Wealth’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$2.54M Sell
5,013
-1,844
-27% -$1.03M 0.58% 52
2022
Q2 		$3.72M Sell
6,857
-372
-5% -$205K 0.76% 28
2022
Q1 		$4.27M Sell
7,229
-4,668
-39% -$2.68M 0.81% 31
2021
Q4 		$7.94M Sell
11,897
-3,931
-25% -$2.45M 1.13% 14
2021
Q3 		$9.04M Sell
15,828
-210
-1% -$115K 1.19% 16
2021
Q2 		$8.09M Sell
16,038
-225
-1% -$106K 1.03% 21
2021
Q1 		$7.42M Sell
16,263
-107
-0.7% -$51.1K 0.98% 22
2020
Q4 		$7.63M Buy
16,370
+201
+1% +$94.2K 1.05% 19
2020
Q3 		$7.14M Sell
16,169
-201
-1% -$83K 1.08% 20
2020
Q2 		$5.93M Sell
16,370
-91
-0.6% -$30.5K 0.97% 23
2020
Q1 		$4.67M Sell
16,461
-237
-1% -$74.7K 0.87% 28
2019
Q4 		$5.42M Buy
16,698
+27
+0.2% +$8.19K 0.81% 31
2019
Q3 		$4.86M Sell
16,671
-466
-3% -$133K 0.72% 37
2019
Q2 		$5.03M Buy
17,137
+90
+0.5% +$24.8K 0.68% 39
2019
Q1 		$4.67M Buy
17,047
+763
+5% +$190K 0.63% 40
2018
Q4 		$3.64M Sell
16,284
-19
-0.1% -$4.46K 0.56% 45
2018
Q3 		$3.98M Sell
16,303
-128
-0.8% -$29.4K 0.53% 44
2018
Q2 		$3.4M Sell
16,431
-74
-0.4% -$15.7K 0.52% 51
2018
Q1 		$3.41M Sell
16,505
-305
-2% -$64K 0.52% 52
2017
Q4 		$3.19M Buy
16,810
+13
+0.1% +$2.49K 0.47% 58
2017
Q3 		$3.18M Sell
16,797
-93
-0.6% -$16.8K 0.55% 48
2017
Q2 		$2.95M Sell
16,890
-265
-2% -$44.5K 0.48% 53
2017
Q1 		$2.63M Buy
17,155
+142
+0.8% +$21.7K 0.48% 58
2016
Q4 		$2.4M Buy
17,013
+285
+2% +$42K 0.51% 57
2016
Q3 		$2.66M Buy
16,728
+250
+2% +$38.5K 0.57% 50
2016
Q2 		$2.44M Buy
16,478
+5,301
+47% +$782K 0.54% 53
2016
Q1 		$1.58M Buy
+11,177
New +$1.5M 0.36% 82

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ACG Wealth's TMO Position: Q3 2022 in Review

ACG Wealth reduced its Thermo Fisher Scientific (TMO) stake by 27% in Q3 2022, selling an estimated $1.03M and leaving 5,013 shares worth $2.54M. The position accounts for 0.58% of the portfolio, ranked #52.

ACG Wealth first reported a position in TMO in Q1 2016 and has held it in 27 quarters since. The position peaked at $9.04M in Q3 2021. 2,266 funds tracked by Wall St. Rank hold TMO as of Q3 2022.

  • ACG Wealth held 5,013 shares of Thermo Fisher Scientific worth $2.54M as of Q3 2022.
  • ACG Wealth sold 1,844 Thermo Fisher Scientific shares in Q3 2022, an estimated $1.03M.
  • Thermo Fisher Scientific made up 0.58% of ACG Wealth's portfolio in Q3 2022, its #52 holding.
  • ACG Wealth first reported a position in Thermo Fisher Scientific in Q1 2016 and has held it in 27 quarters since.
  • ACG Wealth's Thermo Fisher Scientific position peaked at $9.04M in Q3 2021.
  • 2,266 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2022.

Based on ACG Wealth's 13F filing for Q3 2022, filed 3 Nov 2022.